JDD Buzz Series | AI in Dermatology Residency Applications: A Program Director’s Perspective
Applicants for dermatology residency programs are increasingly using artificial intelligence (AI) technology to write or enhance their personal statements, according to a study published in the May Journal of Drugs in Dermatology. Is this ethical? Should applicants disclose AI usage? What role, if any, should AI have in applications for programs, positions, and grants? I …
From the JDD Podcast Vault | Thin Skinned: Topical Steroid Safety and Legal Landmines
Welcome to another installment of “From the JDD Podcast Vault” series! This week, we’re digging into a truly cautionary tale with the episode: Thin Skinned: Topical Steroid Safety and Legal Landmines, hosted by Dr. Adam Friedman and featuring the ever-insightful Dr. Raj Chovatiya. “Just put some salve on it.” Sounds harmless enough, right? But let’s …
JDD Buzz Series | AI in Dermatology Residency Applications
The use of artificial intelligence (AI) programs such as ChatGPT is a source of controversy in academia, including in the college admissions process. Are applicants for dermatology residency programs using AI to write or enhance their personal statements, and if so, to what extent? A study published in the May Journal of Drugs in Dermatology …
Continue reading “JDD Buzz Series | AI in Dermatology Residency Applications”
From the JDD Podcast Vault: Evidence-Based Framing for Improving Treatment Adherence
Welcome to our newest blog series, From the JDD Podcast Vault, where we spotlight standout episodes from the JDD Dermatology Podcast, hosted by the always-engaging Dr. Adam Friedman. Each post will revisit compelling conversations that continue to educate, inspire, and provoke thought in dermatologic practice. In this featured episode, “Wondering About Words: Evidence-Based Framing for …
JDD May 2025 Issue Highlights | Special Focus: Skin Cancer
This month’s Journal of Drugs in Dermatology issue brings forward a diverse collection of studies spanning surgical, medical, and therapeutic dermatology. The May Editor’s Pick presents a robust cost-effectiveness analysis on placental allograft use for same-day Mohs reconstruction, offering insights from more than 2,000 patients. Also featured are a systematic review of cylindrocarcinoma surgical outcomes, …
Continue reading “JDD May 2025 Issue Highlights | Special Focus: Skin Cancer”
JDD April 2025 Issue Highlights: Innovation, Inclusion & Insight in Dermatology
This month’s Journal of Drugs in Dermatology issue is packed with groundbreaking studies and real-world insights spanning across age groups, skin types, and therapeutic categories. From improving dermatoporosis in older adults to exploring an acne management algorithm that smartly integrates acneceuticals, the April Editor’s Picks reflect dermatology’s evolving landscape. Highlights include a look into patient …
Continue reading “JDD April 2025 Issue Highlights: Innovation, Inclusion & Insight in Dermatology”
JDD Buzz Series | Social Media’s Impact on Hair Loss Information
Social media is a major source of medical information, including information about hair loss. How reliable is the hair loss material presented on social media, and how does this information impact patients? Those are some of the questions posed by researchers in a study published in the March Journal of Drugs in Dermatology. I interviewed …
Continue reading “JDD Buzz Series | Social Media’s Impact on Hair Loss Information”
JDD March 2025 Editor’s Picks
Get ready to explore the latest advancements in dermatology with the March issue of the Journal of Drugs in Dermatology! This edition dives deep into cutting-edge research, including AI-driven personalized hair loss treatments, the dermatologic potential of berberine, and the evolving role of social media in hair loss education. Plus, don’t miss insights on acneceuticals, …
JDD Buzz Series | Sunscreens: Mechanisms and Safety in Depth
Despite decades of educational efforts, there is growing public skepticism over sunscreen’s safety and efficacy. Researchers from Chicago sought to synthesize the current scientific understanding of sunscreen in order to help dermatology clinicians address concerns. The findings are published in the February Journal of Drugs in Dermatology. I interviewed author Natalia Chalupczak, medical student at …
Continue reading "JDD Buzz Series | Sunscreens: Mechanisms and Safety in Depth"
JDD February 2025 Editor’s Picks
The February 2025 issue of the Journal of Drugs in Dermatology brings a fresh wave of clinical insights and innovative research to the dermatology community. This edition highlights new perspectives on minoxidil adherence, groundbreaking findings in keloid and hypertrophic scar risk factors, and expert consensus on deucravacitinib for plaque psoriasis. Readers will also discover updates …